EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

Clinical trial NCT06716580 · RECRUITING

Trial details

NCT number: NCT06716580
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer EGFR Gene Mutation

Start date: 2025-04-01
Primary completion: 2027-09-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.